// App-Quantinova.ai

2865 : Dual action glycotherapy for triple negative breast cancer

Researchers

Presenter

  • Dipak K. Banerjee

Principal Investigators

  • Aditi Banerjee

  • Zhenbo Zhang

  • Jesus E. Serrano

  • Eva C. Romero

  • Neysharie Sanchez

  • Krishna Baksi

Medical Centers

  • Univ. of Puerto Rico, San Juan, PR

  • Universidad Central del Caribe, Guaynabo, PR.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

  • Chronic obstructive pulmonary disease

Biomarkers

  • Nucleoside diphosphate kinase A

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • Tunicamycin

  • taxane

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved